XOMA Corp XOMA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
17.26UNCH (UNCH)
Volume
351
Close
17.26quote price arrow up+0.05 (+0.29%)
Volume
43,334
52 week range
16.96 - 39.02
Loading...
  • Open17.19
  • Day High17.59
  • Day Low17.05
  • Prev Close17.21
  • 52 Week High39.02
  • 52 Week High Date06/29/21
  • 52 Week Low16.96
  • 52 Week Low Date05/11/22

Key Stats

  • Market Cap197.11M
  • Shares Out11.42M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change-17.22

KEY STATS

  • Open17.19
  • Day High17.59
  • Day Low17.05
  • Prev Close17.21
  • 52 Week High39.02
  • 52 Week High Date06/29/21
  • 52 Week Low16.96
  • 52 Week Low Date05/11/22
  • Market Cap197.11M
  • Shares Out11.42M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change-17.22

RATIOS/PROFITABILITY

  • EPS (TTM)0.55
  • P/E (TTM)31.48
  • Fwd P/E (NTM)-159.81
  • EBITDA (TTM)21.898M
  • ROE (TTM)11.04%
  • Revenue (TTM)40.89M
  • Gross Margin (TTM)-
  • Net Margin (TTM)51.09%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On XOMA Corp

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
XOMA Corporation is a biotechnology royalty aggregator. The Company’s drug royalty aggregator business is focused on early to mid-stage clinical assets, primarily in Phase I and II. The Company has a portfolio of economic rights and royalty payments associated with partnered pre-commercial therapeutic candidates. It also acquires the economics associated with pre-commercial therapeutic candidates that are licensed to pharmaceutical or biotechnology companies. The Company has...
James Neal
Chairman of the Board, Chief Executive Officer
Thomas Burns
Chief Financial Officer, Senior Vice President - Finance
Address
2200 Powell St Ste 310
Emeryville, CA
94608-1818
United States

Top Peers

SYMBOLLASTCHG%CHG
GTHX
G1 Therapeutics Inc
4.26-0.35-7.59%
ALPN
Alpine Immune Sciences Inc
7.89+0.34+4.50%
MRNS
Marinus Pharmaceuticals Inc
5.49-0.17-3.00%
STRO
Sutro Biopharma Inc
4.74+0.14+3.04%
CLLS
Cellectis SA
3.14-0.03-0.95%